Ángel Pulido-Capiz

6PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 28, 2025
Vitamin D as an Epigenetic Regulator: A Hypothetical Mechanism for Cancer Prevention via Inhibition of Oncogenic lncRNA HOTAIR.

Samuel Trujano-Camacho, Ángel Pulido-Capiz, Victor García-González

|May 07, 2025
Lapatinib-Resistant HER2+ Breast Cancer Cells Are Associated with Dysregulation of MAPK and p70S6K/PDCD4 Pathways and Calcium Management, Influence of Cryptotanshinone.

Jorge Hernández-Valencia, Ruth García-Villarreal, Manuel Rodríguez-Jiménez

|Sep 28, 2024
Auraptene Boosts the Efficacy of the Tamoxifen Metabolites Endoxifen and 4-OH-Tamoxifen in a Chemoresistant ER+ Breast Cancer Model.

Angel Pulido-Capiz, Brenda Chimal-Vega, Luis Pablo Avila-Barrientos

|Apr 27, 2024
Low-Density Lipoproteins Increase Proliferation, Invasion, and Chemoresistance via an Exosome Autocrine Mechanism in MDA-MB-231 Chemoresistant Cells.

César Y Castañeda-Sánchez, Brenda Chimal-Vega, Roberto León-Gutiérrez

|Dec 23, 2022
eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model.

Alina González-Ortiz, Angel Pulido-Capiz, César Y Castañeda-Sánchez

|Oct 16, 2018
Protein translation associated to PERK arm is a new target for regulation of metainflammation: A connection with hepatocyte cholesterol.

Octavio Galindo-Hernández, Iván Córdova-Guerrero, Laura Janeth Díaz-Rubio

Pageof 1